The World Health Organization had suspended clinical trial programs using hydroxychloroquine following the initial report, as did the U.K. and France. The Lancet’s peer-reviewed study, published on May 22, claimed to have analyzed Surgisphere data collected from almost 96,000 Covid-19 patients across the globe.
But in the days after publication, concerns over the underlying data bubbled up. Questions arose over how Surgisphere, a little-known company that claims to have 11 employees, could have reached agreements on sharing sensitive patient information with some 1,200 hospitals around the world, much less received and processed the data so quickly.
Surgisphere Corp.
Browse the articles related to this topic below.
Join our community on Guilded.